RenovoRx (RNXT) Short Interest Ratio & Short Volume $1.29 +0.08 (+6.61%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends RenovoRx Short Interest DataRenovoRx (RNXT) has a short interest of 71,900 shares, representing 0.31% of the float (the number of shares available for trading by the public). This marks a -21.76% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 46,124 shares to cover all short positions.Current Short Interest71,900 sharesPrevious Short Interest91,900 sharesChange Vs. Previous Month-21.76%Dollar Volume Sold Short$71,756.20Short Interest Ratio2.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares24,000,000 sharesFloat Size23,530,000 sharesShort Percent of Float0.31%Today's Trading Volume262,792 sharesAverage Trading Volume46,124 sharesToday's Volume Vs. Average570% Short Selling RenovoRx? Sign up to receive the latest short interest report for RenovoRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRNXT Short Interest Over TimeRNXT Days to Cover Over TimeRNXT Percentage of Float Shorted Over Time Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. RenovoRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202471,900 shares $71,756.20 -21.8%0.3%2.2 $1.00 10/15/202491,900 shares $90,990.19 -19.6%0.4%2.8 $0.99 9/30/2024114,300 shares $121,158.00 +121.9%0.5%3.4 $1.06 9/15/202451,500 shares $57,963.25 -5.3%0.2%1.6 $1.13 8/31/202454,400 shares $55,488.00 -11.1%0.2%1.3 $1.02 8/15/202461,200 shares $67,932.00 +3.4%0.3%1.4 $1.11 Get the Latest News and Ratings for RNXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. 7/31/202459,200 shares $71,040.00 +7.8%0.3%1.4 $1.20 7/15/202454,900 shares $69,723.00 +24.8%0.2%1.4 $1.27 6/30/202444,000 shares $49,720.00 +13.7%0.2%0.8 $1.13 6/15/202438,700 shares $45,666.00 -37.2%0.2%0.7 $1.18 5/31/202461,600 shares $71,456.00 +21.3%0.3%1.6 $1.16 5/15/202450,800 shares $70,104.00 +28.9%0.2%1.4 $1.38 4/30/202439,400 shares $50,038.00 -39.9%0.2%1 $1.27 4/15/202465,500 shares $75,980.00 +274.3%0.5%1.4 $1.16 3/31/202417,500 shares $23,450.00 +12.2%0.1%0.3 $1.34 3/15/202415,600 shares $20,592.00 +129.4%0.2%0.2 $1.32 2/29/20246,800 shares $11,696.00 -47.3%0.1%0.1 $1.72 2/15/202412,900 shares $18,189.00 +69.7%0.2%0.1 $1.41 1/31/20247,600 shares $11,400.00 -78.2%0.1%0.1 $1.50 1/15/202434,900 shares $38,390.00 +156.6%0.4%0.4 $1.10 12/31/202313,600 shares $31,144.00 -80.7%0.2%0.2 $2.29 12/15/202370,600 shares $60,363.00 +215.2%0.8%1.8 $0.86 11/30/202322,400 shares $14,336.00 +16.1%0.3%1.1 $0.64 11/15/202319,300 shares $14,282.00 -45.0%0.2%1 $0.74 10/31/202335,100 shares $40,014.00 -10.0%0.4%1.7 $1.14 10/15/202339,000 shares $43,290.00 -10.8%0.4%1.5 $1.11 9/30/202343,700 shares $58,121.00 +33.2%0.5%1.1 $1.33 9/15/202332,800 shares $54,448.00 -17.2%0.4%0.1 $1.66 8/31/202339,600 shares $64,152.00 -43.9%0.5%0.1 $1.62 8/15/202370,600 shares $124,962.00 -23.1%0.8%0.1 $1.77 7/31/202391,800 shares $181,764.00 -47.7%1.1%0.2 $1.98 7/15/2023175,500 shares $377,325.00 +1,540.2%2.1%0.3 $2.15 6/30/202310,700 shares $24,182.00 +21.6%0.1%0 $2.26 6/15/20238,800 shares $19,712.00 -50.0%0.1%0.2 $2.24 5/31/202317,600 shares $32,912.00 +35.4%0.2%0.5 $1.87 5/15/202313,000 shares $28,990.00 -49.6%0.2%0.2 $2.23 4/30/202325,800 shares $80,754.00 -17.6%0.4%0.5 $3.13 4/15/202331,300 shares $87,640.00 -1.3%0.4%0.5 $2.80 3/31/202331,700 shares $110,474.50 +173.3%0.4%0.5 $3.49 3/15/202311,600 shares $38,164.00 +31.8%0.2%0.2 $3.29Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 2/28/20238,800 shares $40,920.00 -63.8%0.1%0.1 $4.65 2/15/202324,300 shares $98,658.00 -28.1%0.3%0.6 $4.06 1/31/202333,800 shares $88,894.00 +44.4%0.5%0.8 $2.63 1/15/202323,400 shares $70,434.00 -10.3%0.3%0.7 $3.01 12/30/202226,100 shares $61,335.00 -18.7%0.4%1.3 $2.35 12/15/202232,100 shares $72,225.00 +124.5%0.4%2.1 $2.25 11/30/202214,300 shares $27,885.00 +107.3%0.2%1.4 $1.95 11/15/20226,900 shares $13,524.00 +15.0%0.1%0.6 $1.96 10/31/20226,000 shares $10,500.00 -10.5%0.1%0.4 $1.75 10/15/20226,700 shares $11,524.00 -46.4%0.1%0.4 $1.72 9/30/202212,500 shares $25,250.00 -22.4%0.2%0.7 $2.02 9/15/202216,100 shares $42,021.00 +3.9%0.2%0.9 $2.61 8/31/202215,500 shares $32,550.00 +9.9%0.2%0.9 $2.10 8/15/202214,100 shares $33,699.00 -37.3%0.2%0.9 $2.39 7/31/202222,500 shares $43,751.25 +64.2%0.3%1.5 $1.94 7/15/202213,700 shares $26,578.00 -50.2%0.2%0.8 $1.94 6/30/202227,500 shares $54,450.00 -27.3%0.4%1.1 $1.98 6/15/202237,800 shares $77,868.00 +29.5%0.6%1.2 $2.06 5/31/202229,200 shares $57,232.00 +13.2%0.5%0.5 $1.96 5/15/202225,800 shares $46,956.00 -6.9%0.4%0.4 $1.82 4/30/202227,700 shares $46,259.00 -49.5%0.4%0.4 $1.67 4/15/202254,900 shares $142,191.00 -12.4%0.9%0.8 $2.59 3/31/202262,700 shares $183,711.00 +85.0%1.0%0.9 $2.93 3/15/202233,900 shares $97,293.00 -58.2%0.6%0.3 $2.87 2/28/202281,100 shares $272,496.00 -33.4%1.3%0.6 $3.36 2/15/2022121,800 shares $473,802.00 +84.0%2.0%0.3 $3.89 1/31/202266,200 shares $219,784.00 -51.0%1.0%0 $3.32 1/15/2022135,100 shares $548,506.00 +1.8%2.0%0.1 $4.06 12/31/2021132,700 shares $642,268.00 No Change2.0%0 $4.84 RNXT Short Interest - Frequently Asked Questions What is RenovoRx's current short interest? Short interest is the volume of RenovoRx shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 71,900 shares of RNXT short. 0.31% of RenovoRx's shares are currently sold short. Learn More on RenovoRx's current short interest. What is a good short interest ratio for RenovoRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNXT shares currently have a short interest ratio of 2.0. Learn More on RenovoRx's short interest ratio. What is a good short interest percentage for RenovoRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.31% of RenovoRx's floating shares are currently sold short. Is RenovoRx's short interest increasing or decreasing? RenovoRx saw a decline in short interest in October. As of October 31st, there was short interest totaling 71,900 shares, a decline of 21.8% from the previous total of 91,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is RenovoRx's float size? RenovoRx currently has issued a total of 24,000,000 shares. Some of RenovoRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RenovoRx currently has a public float of 23,530,000 shares. How does RenovoRx's short interest compare to its competitors? 0.31% of RenovoRx's shares are currently sold short. Here is how the short interest of companies compare to RenovoRx: FibroGen, Inc. (4.29%), Cyclo Therapeutics, Inc. (0.69%), CalciMedica, Inc. (1.36%), Rockwell Medical, Inc. (3.29%), Adverum Biotechnologies, Inc. (13.39%), Context Therapeutics Inc. (1.72%), Alto Neuroscience, Inc. (20.78%), Rani Therapeutics Holdings, Inc. (7.18%), Journey Medical Co. (0.61%), Vaxart, Inc. (4.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short RenovoRx stock? Short selling RNXT is an investing strategy that aims to generate trading profit from RenovoRx as its price is falling. RNXT shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RenovoRx? A short squeeze for RenovoRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RNXT, which in turn drives the price of the stock up even further. How often is RenovoRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNXT, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies FGEN Short Interest Data CYTH Short Interest Data CALC Short Interest Data RMTI Short Interest Data ADVM Short Interest Data CNTX Short Interest Data ANRO Short Interest Data RANI Short Interest Data DERM Short Interest Data VXRT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNXT) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
